Letter to the Editor

Editor, – I need to inform readers of a correction to the article 'Inside the isomers: the tale of chiral switches' (Aust Prescr 2004;27:109-13). On page 47 under Introduction, I cited salmeterol as a single enantiomer drug, however, it is currently marketed as the racemate - noting that the R enantiomer is the active species.

Andrew Somogyi
Associate Professor
Department of Clinical & Experimental Pharmacology
University of Adelaide

The Editorial Executive Committee welcomes letters, which should be less than 250 words. Before a decision to publish is made, letters which refer to a published article may be sent to the author for a response. Any letter may be sent to an expert for comment. When letters are published, they are usually accompanied in the same issue by their responses or comments. The Committee screens out discourteous, inaccurate or libellous statements. The letters are sub-edited before publication. Authors are required to declare any conflicts of interest. The Committee's decision on publication is final